DK173185B1 - 1-Cyclopropyl-7-[3-(substitueret amino)methyl-1-pyrrolidinyl]-6-flour-1,4-dihydro-4-oxo-3-quinolincarboxylsyrederivater, fr - Google Patents

1-Cyclopropyl-7-[3-(substitueret amino)methyl-1-pyrrolidinyl]-6-flour-1,4-dihydro-4-oxo-3-quinolincarboxylsyrederivater, fr Download PDF

Info

Publication number
DK173185B1
DK173185B1 DK198505199A DK519985A DK173185B1 DK 173185 B1 DK173185 B1 DK 173185B1 DK 198505199 A DK198505199 A DK 198505199A DK 519985 A DK519985 A DK 519985A DK 173185 B1 DK173185 B1 DK 173185B1
Authority
DK
Denmark
Prior art keywords
cyclopropyl
dihydro
oxo
fluoro
chloro
Prior art date
Application number
DK198505199A
Other languages
Danish (da)
English (en)
Other versions
DK519985D0 (da
DK519985A (da
Inventor
Tsutomu Irikura
Seigo Suzue
Keiji Hirai
Takayoshi Ishizaki
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Publication of DK519985D0 publication Critical patent/DK519985D0/da
Publication of DK519985A publication Critical patent/DK519985A/da
Application granted granted Critical
Publication of DK173185B1 publication Critical patent/DK173185B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Table Devices Or Equipment (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK198505199A 1984-11-13 1985-11-12 1-Cyclopropyl-7-[3-(substitueret amino)methyl-1-pyrrolidinyl]-6-flour-1,4-dihydro-4-oxo-3-quinolincarboxylsyrederivater, fr DK173185B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23912484 1984-11-13
JP59239124 1984-11-13

Publications (3)

Publication Number Publication Date
DK519985D0 DK519985D0 (da) 1985-11-12
DK519985A DK519985A (da) 1986-07-01
DK173185B1 true DK173185B1 (da) 2000-03-06

Family

ID=17040142

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198505199A DK173185B1 (da) 1984-11-13 1985-11-12 1-Cyclopropyl-7-[3-(substitueret amino)methyl-1-pyrrolidinyl]-6-flour-1,4-dihydro-4-oxo-3-quinolincarboxylsyrederivater, fr

Country Status (21)

Country Link
EP (1) EP0183129B1 (fi)
JP (1) JPH0637490B2 (fi)
KR (2) KR920006236B1 (fi)
CN (1) CN1011587B (fi)
AT (1) ATE45354T1 (fi)
AU (1) AU591640B2 (fi)
CA (2) CA1290338C (fi)
DE (1) DE3572170D1 (fi)
DK (1) DK173185B1 (fi)
ES (2) ES8704929A1 (fi)
FI (1) FI83219C (fi)
GR (1) GR852758B (fi)
HU (1) HU198471B (fi)
IE (1) IE58356B1 (fi)
IN (2) IN162769B (fi)
MX (1) MX162894B (fi)
NO (1) NO163568C (fi)
NZ (1) NZ214156A (fi)
PH (1) PH21007A (fi)
PT (1) PT81476B (fi)
ZA (1) ZA858699B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IL77846A (en) * 1985-03-25 1989-08-15 Warner Lambert Co Process for the preparation of 7-amino-quinolin-4-oxy-3-carboxylic acid derivatives
JPS62108878A (ja) * 1985-11-05 1987-05-20 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体およびその製造方法
US4692454A (en) * 1986-02-03 1987-09-08 Warner-Lambert Company Opthalmic use of quinolone antibiotics
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPS63179856A (ja) * 1987-01-21 1988-07-23 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法並びにその中間体
NO885426L (no) * 1987-12-11 1989-06-12 Dainippon Pharmaceutical Co Kinolinderivater, samt fremgangsmaate ved fremstilling derav.
US5233091A (en) * 1988-06-21 1993-08-03 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
US4885386A (en) * 1988-10-28 1989-12-05 Warner-Lambert Company Process for the synthesis of 3-chloro-2,4,5-trifluorobenzoic acid
DE3918544A1 (de) * 1989-06-07 1990-12-13 Bayer Ag Verfahren zur herstellung von 7-(3-amino- sowie 3-amino-methyl-1-pyrrolidinyl)-3-chinolon- carbonsaeuren sowie -naphthyridoncarbonsaeuren
ES2018977A6 (es) * 1989-11-29 1991-05-16 Marga Investigacion Procedimiento de preparacion de n-ciclopropil-4-fluoroanilinas.
FR2673426B1 (fr) * 1991-03-01 1993-07-16 Bouchara Sa Nouvelles quinolones, leur procede de preparation et les compositions en refermant.
KR950014567B1 (ko) * 1991-08-01 1995-12-08 주식회사대웅제약 신규한 퀴놀론 카르복실산 유도체
CN1065802C (zh) * 1992-02-08 2001-05-16 大野家建 研磨机及其自动化装置
DE69509442T2 (de) * 1994-06-16 1999-09-02 Lg Chemical Ltd. Chinolincarbonsäurederivate mit 7-(4-Amino-methyl-3-oxim)-pyrrolidin-Substituenten und Verfahren zu ihrer Herstellung
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel

Also Published As

Publication number Publication date
IN162769B (fi) 1988-07-09
IE58356B1 (en) 1993-09-08
CA1282412C (en) 1991-04-02
HUT40101A (en) 1986-11-28
HU198471B (en) 1989-10-30
CN85109026A (zh) 1986-07-30
ES548800A0 (es) 1987-04-16
AU591640B2 (en) 1989-12-14
IN164295B (fi) 1989-02-11
KR930004652B1 (ko) 1993-06-02
FI83219C (fi) 1991-06-10
NO163568B (no) 1990-03-12
JPS61267573A (ja) 1986-11-27
FI854445A0 (fi) 1985-11-12
ES8704929A1 (es) 1987-04-16
ATE45354T1 (de) 1989-08-15
ES8802148A1 (es) 1988-04-01
NO163568C (no) 1990-06-20
KR920006236B1 (ko) 1992-08-01
DK519985D0 (da) 1985-11-12
DK519985A (da) 1986-07-01
GR852758B (fi) 1986-02-25
NO854522L (no) 1986-05-14
KR860004025A (ko) 1986-06-16
ES557306A0 (es) 1988-04-01
EP0183129A1 (en) 1986-06-04
KR860004049A (ko) 1986-06-16
ZA858699B (en) 1986-07-30
EP0183129B1 (en) 1989-08-09
FI854445A (fi) 1986-05-14
CA1290338C (en) 1991-10-08
PT81476B (pt) 1987-11-11
IE852790L (en) 1986-05-13
DE3572170D1 (de) 1989-09-14
CN1011587B (zh) 1991-02-13
JPH0637490B2 (ja) 1994-05-18
FI83219B (fi) 1991-02-28
MX162894B (es) 1991-07-08
AU4946185A (en) 1986-05-22
NZ214156A (en) 1988-06-30
PH21007A (en) 1987-06-23
PT81476A (en) 1985-12-01

Similar Documents

Publication Publication Date Title
DK173185B1 (da) 1-Cyclopropyl-7-[3-(substitueret amino)methyl-1-pyrrolidinyl]-6-flour-1,4-dihydro-4-oxo-3-quinolincarboxylsyrederivater, fr
EP0237955B1 (en) Quinolonecarboxylic acid derivatives and their preparation
KR0130931B1 (ko) 항균제
US4980470A (en) 8-alkoxyquinolonecarboxylic acid and salts thereof
US4753953A (en) Pyridonecarboxylic acid derivatives and antibacterial pharmaceutical compositions thereof
GB2057440A (en) Quinoline carboxylic acid derivatives
HU199821B (en) Process for production of derivatives of in 8 position substituated quinoline carbonic acid and medical compositions containing them
JPH05239051A (ja) 7−イソインドリニル−キノロン−および−ナフチリドンカルボン酸誘導体
JPH06279411A (ja) キノリンカルボン酸誘導体
KR930011036B1 (ko) 퀴놀론카복실산 유도체의 제조방법
NO852076L (no) Fremgangsmaate ved fremstilling av kinolinkarboksylsyrederivater.
EP0181521A1 (en) Antimicrobial 1-substituted Phenyl-4-oxoquinoline-3-carboxylic acid compounds
EP0178388A1 (en) Quinolinecarboxylic acid derivatives
JPS61186379A (ja) 1‐シクロプロピル‐1,4‐ジヒドロ‐4‐オキソ‐7‐[4‐(2‐オキソ‐1,3‐ジオキソル‐4‐イル‐メチル)‐1‐ピペラジニル]‐3‐キノリンカルボン酸
US4826982A (en) Quinolonecarboxylic acid derivatives
US5585491A (en) Antibacterial agents
IE911227A1 (en) Quinolinecarboxylic acid antibacterial agents
JPS6272686A (ja) キノリン誘導体
JPH0680640A (ja) 選択毒性に優れた8−アルコキシキノロンカルボン酸およびその塩並びにその製造方法
JP2523092B2 (ja) ベンゼン誘導体

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK